Specialty pharmacists can help patients changing payers or providers, and specialty pharmacy data helps with medication adherence strategies.
Specialty Pharmacy Data for Medication Adherence Read More »
A look at pharma market insights plus regulatory news updates from the FDA and related agencies to wrap up 2023.
2023 Wrap-Up: Regulatory Updates in Specialty Pharma Read More »
Cell and gene therapies in development today provide real world evidence analytics for how rare diseases will be treated tomorrow.
Real-World Evidence in Cell and Gene Therapies Read More »
Join us for a fireside chat with Mike McDole from Aveo, an oncology-focused biopharmaceutical company that will discuss challenges and opportunities when it comes to trade operations and growing the customer base. Be a part of this discussion on ways to optimize trade operations and patient management through a centralized patient aggregation solution and opportunities
Webinar: Optimizing Trade Operations and Patient Management Read More »
The Pharmaceutical Management Science Association (PMSA) Fall Symposium is a premier event for pharma data science professionals and we’re excited to attend. PMSA’s Fall Symposium is a great opportunity to have in-depth engagement with attendees from the pharmaceutical industry. The Symposium aims to serve the needs of an analytical area with the goals of raising
PMSA 2023 Fall Symposium Read More »
Competing Humira biosimilars are already on the market. Examining them provides pharma market insights such as specialty pharmacy trends and a go-to-market strategy.
Lessons from Humira’s Biosimilars for Specialty Pharma Read More »
Specialty pharmacy data from patient journey orchestration and specialty pharmacy analytics helps specialty pharmacies outperform competitors.
Gaining Competitive Advantage with Specialty Pharmacy Data Read More »
Rare disease patient data is generated from a wide range of sources. We examine specialty pharmacy data and rare disease registries.
Harnessing Specialty Pharmacy Data for Rare Disease Insights Read More »
The very name “rare disease” implies that the average person should expect to meet someone with a rare disease infrequently, if ever. Each individual rare disease in fact affects only a small portion of the human population. Taken together, rare diseases as a whole affect millions of people worldwide. Those who have a rare disease
Improving Rare Disease Drug Development and Market Access Through Data Read More »
As work on genetics has advanced, so has the creation of biologics and biosimilars. Today, biosimilars are more common, changing the specialty drug landscape.
How Biosimilars are Changing the Specialty Drug Landscape Read More »